Keywords: Hypercholesterolemia, Cholesterol lowerers, GlobalData

Hypercholesterolemia therapeutics market forecast to show moderate growth

Article | 28 July 2011

The value of the global hypercholesterolemia therapeutics - cholesterol lowerers - market was put at $29.4 billion in 2010 and is forecast ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in